Xanamem: Alzheimer’s breakthrough set for 2025, 2026
The search for an effective treatment for neurological conditions like Alzheimer’s disease…
Actinogen Medical Limited (ASX:ACW)
About Actinogen Medical Limited
Key Information
ACW In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 02/04/2025 | ACW CMO presents Xanamem pTau poster at ADPD25 conference | 604.16KB | 541 |
| 27/03/2025 | Price Sensitive PS ACW conducts Type C meeting with FDA regarding depression | 236.28KB | 637 |
| 26/03/2025 | Actinogen presentation to ASX small & mid-caps conference | 1.38MB | 4.2K |
| 24/03/2025 | Appendix 3Ys x 5 | 359.07KB | 366 |
| 24/03/2025 | Notification of cessation of securities - ACW | 12.78KB | 251 |
| 24/03/2025 | Notification of cessation of securities - ACW | 12.83KB | 243 |
| 24/03/2025 | Application for quotation of securities - ACW | 18.02KB | 270 |
| 14/03/2025 | Results of Meeting | 280.27KB | 496 |